| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 941.57 | 1702.17 | 1467.24 | -550.36 | 10.20 |
| | | | | | |
| Net CashFlow From Operating Activities | 2028.20 | 1582.46 | 1059.79 | 2546.70 | 2656.68 |
| Net Cash Used In Investing Activities | -1793.44 | -854.16 | -2095.71 | -840.98 | -1356.45 |
| Net Cash Used From Financing Activities | 398.24 | -518.73 | 1186.43 | -1483.76 | -705.52 |
| Foreign Exchange Gains / Losses | 0.00 | 0.69 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 633.00 | 210.27 | 150.50 | 221.97 | 594.71 |
| Cash And Cash Equivalents Begin of Year | 2523.96 | 2313.69 | 2163.19 | 1933.50 | 1338.79 |
| Cash And Cash Equivalents End Of Year | 3156.97 | 2523.96 | 2313.69 | 2155.47 | 1933.50 |